Elastin Biosciences to Join 2024 BIO International Convention in San Diego

Elastin Biosciences, a spin-off from Longaevus Technologies, will participate in the 2024 BIO International Convention in San Diego, June 3-6, 2024.

Elastin Biosciences, a spin-off from Longaevus Technologies, will participate in the 2024 BIO International Convention in San Diego, June 3-6, 2024. CEO Sherif Idriss, Ph.D., will present their promising Elastin Restoration Platform, highlighting recent preclinical successes in treating elastin deficiency-related diseases, such as abdominal aortic aneurysm and Williams syndrome.

Dr. Idriss will engage in one-on-one meetings to explore partnerships and collaborations aimed at accelerating the development of their innovative therapies, with Phase 1 clinical trials targeted for the first half of 2025.

About Elastin Biosciences:

Elastin Biosciences focuses on developing small molecule therapies to combat diseases linked to elastin deficiency. Their Elastin Restoration Platform has shown significant potential in increasing elastin expression and arterial strength in preclinical models.

For more information, visit elastin-biosciences.com.